Trocars Market Size
The global trocars market reached US$ 812.33 million in 2024 and is expected to reach US$ 1,417.87 million by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.
A trocar is a surgical tool used to create access to body cavities during various medical procedures. Trocars are most commonly used in laparoscopic or minimally invasive surgeries, where smaller incisions are preferred to reduce recovery time, minimize scarring, and decrease the risk of infection. These tools are crucial in surgeries like laparoscopy, arthroscopy, and certain types of endoscopy, as they enable doctors to perform complex procedures with minimal disruption to the body.
It’s typically made of a sharp, pointed device, often steel, which is attached to a hollow tube or cannula. This allows surgeons to puncture the body’s tissue safely, providing a pathway for inserting other tools, such as cameras or surgical instruments, into the body.
Executive Summary
Market Dynamics: Drivers & Restraints
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases, such as diabetes, cancer, heart disease, stroke, gastrointestinal disorders, liver illnesses, and obesity, is a significant driver for the trocars market. These conditions often necessitate surgical interventions, leading to a higher demand for trocars, which are essential tools in minimally invasive procedures like laparoscopy.
Trocars are commonly used in surgeries that address complications associated with various chronic diseases. In chronic obstructive pulmonary disease (COPD), trocars can be used during thoracoscopy for procedures like lung volume reduction or lung transplantation. In chronic kidney disease (CKD), trocars assist in minimally invasive kidney transplants or nephrectomies. For instance, according to the American Lung Association in 2024, COPD affects approximately 11.7 million adults in the United States and results in hundreds of thousands of emergency department visits and an estimated $50 billion in healthcare costs annually. COPD includes conditions such as chronic bronchitis and emphysema. In 2022, 4.6% of adults in the U.S. were diagnosed with COPD.
Furthermore, the rising geriatric population, which is more susceptible to chronic diseases, is also expected to drive the demand for surgical procedures, thereby expanding the trocars market.
Risk of Complications
The risk of complications associated with trocar use is expected to be a significant restraint for the trocar market. Although trocars are designed to be safe, improper use or placement can lead to injury to surrounding tissues, such as blood vessels, organs, or nerves. These complications can result in additional surgical procedures, longer recovery times, and higher healthcare costs, all of which can deter hospitals and surgeons from adopting or increasing their use of trocars.
For more details on this report – Request for Sample
Market Segment Analysis
The global Trocars market is segmented based on product type, application, end-user, and region.
Product Type:
Disposable trocars segment is expected to dominate the global trocars market share
The disposable trocars segment is expected to dominate the trocars market due to several factors. These trocars are increasingly important in laparoscopic and diagnostic laparoscopy procedures. They are favored for their cost-effectiveness, user-friendliness, and enhanced safety compared to reusable options. Because they are disposable, each surgery can be set up quickly and easily while maintaining sterility, lowering the risk of infection, and requiring no reprocessing.
The convenience they offer, along with the elimination of sterilization needs and reduced risk of cross-contamination, further drives their growth. This aligns with the increasing focus on infection control measures and the rising demand for single-use surgical instruments.
Market Geographical Share
North America is expected to hold a significant position in the global trocars market share
North America's leading position in the trocars market is expected to continue, driven by several factors. The region boasts a strong healthcare system, significant healthcare spending, and a considerable presence of major companies in the field. North America has been quick to embrace advanced surgical technologies, with a growing trend towards minimally invasive procedures.
The rising rates of chronic conditions like cancer, lung diseases, diabetes, cardiovascular diseases, and obesity are also increasing the need for surgical interventions that utilize trocars. For instance, according to the National Institute of Health in 2023, primary spontaneous pneumothorax mainly occurs at 20-30 years of age. The incidence of PSP in the United States is 7 per 100,000 men and 1 per 100,000 women per year. Trocars are utilized in the treatment of primary spontaneous pneumothorax (PSP) during video-assisted thoracoscopic surgery (VATS). This data indicates a strong correlation between the increasing prevalence of lung diseases and the growth of the trocars market in North America.
Additionally, the strategic activities of market players, such as introducing new products, contribute to market growth in the region.
Major Global Players
The major global players in the trocars market include Conmed Corporation, The Cooper Companies Inc, Teleflex Incorporated, Medtronic Plc, B. Braun Medical Inc, JOHNSON & JOHNSON, Laprosurge, Purple Surgical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Peters Surgical among others.
| Metrics | Details | |
| CAGR | 6.41% | |
| Market Size Available for Years | 2022-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Mn) | |
| Segments Covered | Product Type | Bladeless Trocars, Bladed Trocars, Disposable Trocars, Reusable Trocars, Optical Trocars, Blunt Trocars, Others |
| Application | General Surgery, Gynecological Surgery, Urological Surgery, Pediatric Surgery, Others | |
| End-User | Hospitals, Ambulatory Surgical Centers, Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The Global Trocars Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2025
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
